Niagen Bioscience Financial Overview
Niagen Bioscience's market cap is currently $514.75M. The company's EPS TTM is $0.05; its P/E ratio is 26.66; Niagen Bioscience is scheduled to report earnings on November 4, 2025, and the estimated EPS forecast is $0.02. See an overview of income statement, balance sheet, and cash flow financials.
